粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体

Polyclonal Antibody to Colony Stimulating Factor 2, Granulocyte Macrophage (GMCSF)

CSF2; GM-CSF; Sargramostim; Molgramostin; Granulocyte-Macrophage Colony Stimulating Factor

  • 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 产品包装(模拟)
  • 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 产品包装(模拟)
  • 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 Figure. DAB staining on IHC-P; Samples: Human Brain Tissue.
  • 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 Figure. DAB staining on IHC-P;
    Samples: Human Pancreas Tissue.
  • 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 Figure. DAB staining on IHC-P;
    Samples: Human Stomach Tissue.
  • 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 Figure. DAB staining on IHC-P;
    Samples: Human Stomach Cancer Tissue.
  • PAA045Hu06.jpg Figure. Western Blot; Sample: Recombinant GMCSF, Human.
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对GMCSF的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别GMCSF。

用法

Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
EPA045Hu61 粒细胞巨噬细胞集落刺激因子(GMCSF)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA045Hu61 粒细胞巨噬细胞集落刺激因子(GMCSF)活性蛋白 Cell culture; Activity Assays.
APA045Hu01 粒细胞巨噬细胞集落刺激因子(GMCSF)活性蛋白 Cell culture; Activity Assays.
RPA045Hu01 粒细胞巨噬细胞集落刺激因子(GMCSF)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA045Hu01 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 WB; IHC; ICC; IP.
PAA045Hu06 粒细胞巨噬细胞集落刺激因子(GMCSF)多克隆抗体 WB; IHC; ICC; IP.
MAA045Hu22 粒细胞巨噬细胞集落刺激因子(GMCSF)单克隆抗体 WB; IHC; ICC; IP.
SEA045Hu 粒细胞巨噬细胞集落刺激因子(GMCSF)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA045Hu 粒细胞巨噬细胞集落刺激因子(GMCSF)检测试剂盒(化学发光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
KSA045Hu01 粒细胞巨噬细胞集落刺激因子(GMCSF)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Journal of Toxicology and Environmental Health Effects of 900-MHz Microwave Radiation on γ-Ray-Induced Damage to Mouse Hematopoietic System [PubMed: 20391130]
The Lancet Infectious Diseases Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial [Pubmed:24525316]
留言咨询